羟钴胺治疗难治性低血压和休克：病例系列 - Suppr | 超能文献

相似文献

1

Hydroxocobalamin treatment for refractory hypotension and shock: a case series.羟钴胺治疗难治性低血压和休克：病例系列

Can J Anaesth. 2025 Jan;72(1):208-210. doi: 10.1007/s12630-024-02881-4. Epub 2024 Dec 16.

2

Hydroxocobalamin for Vasodilatory Hypotension in Shock: A Systematic Review With Meta-Analysis for Comparison to Methylene Blue.羟钴胺治疗休克性血管舒张性低血压：与亚甲蓝比较的系统评价与荟萃分析

J Cardiothorac Vasc Anesth. 2023 Sep;37(9):1757-1772. doi: 10.1053/j.jvca.2023.04.006. Epub 2023 Apr 7.

3

Hydroxocobalamin in Refractory Septic Shock: A Retrospective Case Series.用于难治性感染性休克的羟钴胺素：一项回顾性病例系列研究

Crit Care Explor. 2021 Apr 26;3(4):e0408. doi: 10.1097/CCE.0000000000000408. eCollection 2021 Apr.

4

High-Dose IV Hydroxocobalamin (Vitamin B12) in Septic Shock: A Double-Blind, Allocation-Concealed, Placebo-Controlled Single-Center Pilot Randomized Controlled Trial (The Intravenous Hydroxocobalamin in Septic Shock Trial).高剂量静脉注射羟钴胺素（维生素 B12）治疗脓毒性休克的双盲、分配隐藏、安慰剂对照、单中心先导随机对照试验（脓毒性休克羟钴胺素静脉注射试验）。

Chest. 2023 Feb;163(2):303-312. doi: 10.1016/j.chest.2022.09.021. Epub 2022 Sep 26.

5

Use of Hydroxocobalamin (Vitamin B12a) in Patients With Vasopressor Refractory Hypotension After Cardiopulmonary Bypass: A Case Series.羟钴胺素（维生素 B12a）在体外循环后血管加压药抵抗性低血压患者中的应用：病例系列。

Anesth Analg. 2019 Jul;129(1):e1-e4. doi: 10.1213/ANE.0000000000003648.

6

Use of Intravenous Hydroxocobalamin without Methylene Blue for Refractory Vasoplegic Syndrome After Cardiopulmonary Bypass.心肺转流术后难治性血管扩张性休克使用羟钴胺静脉注射而不使用亚甲蓝。

Am J Case Rep. 2021 Jun 18;22:e930890. doi: 10.12659/AJCR.930890.

7

Rescue of Nimodipine-Induced Refractory Vasoplegia With Hydroxocobalamin in Subarachnoid Hemorrhage: A Case Report.用羟钴胺抢救蛛网膜下腔出血中尼莫地平引起的难治性血管麻痹：一例报告

Crit Care Explor. 2020 Sep 23;2(10):e0205. doi: 10.1097/CCE.0000000000000205. eCollection 2020 Oct.

8

Intraoperative Versus Postoperative Hydroxocobalamin for Vasoplegic Shock in Cardiothoracic Surgery.心胸外科手术中血管扩张性休克患者术中与术后使用羟钴胺的比较。

J Cardiothorac Vasc Anesth. 2023 Dec;37(12):2538-2545. doi: 10.1053/j.jvca.2023.08.145. Epub 2023 Aug 25.

9

Treatment of refractory shock with vitamin B : A narrative review.维生素 B 治疗难治性休克：一篇叙述性评论。

Nutr Clin Pract. 2024 Apr;39(2):356-365. doi: 10.1002/ncp.11095. Epub 2023 Nov 29.

10

Hydroxocobalamin for treatment of catecholamine-resistant vasoplegia during liver transplantation: A single-center series of 20 cases.羟钴胺素用于治疗肝移植期间儿茶酚胺抵抗性血管麻痹：一项20例的单中心研究系列

Int J Surg Case Rep. 2022 Sep;98:107488. doi: 10.1016/j.ijscr.2022.107488. Epub 2022 Aug 10.

本文引用的文献

1

An updated "norepinephrine equivalent" score in intensive care as a marker of shock severity.在重症监护中，更新的“去甲肾上腺素等效评分”作为休克严重程度的标志物。

Crit Care. 2023 Jan 20;27(1):29. doi: 10.1186/s13054-023-04322-y.

2

Lower Versus Higher Exposure to Vasopressor Therapy in Vasodilatory Hypotension: A Systematic Review With Meta-Analysis.低血压时低剂量与高剂量血管加压素治疗的比较：系统评价与荟萃分析。

Crit Care Med. 2023 Feb 1;51(2):254-266. doi: 10.1097/CCM.0000000000005736. Epub 2022 Nov 18.

3

Hydroxocobalamin in Refractory Septic Shock: A Retrospective Case Series.